Charles River Laboratories International (CRL) Stock Forecast for 2023 – 2026. Sell or Buy Prediction

Charles River Laboratories International (CRL) Stock Forecast for 2023 – 2026. Sell or Buy?

Updated: December 5, 2023 (16:01)

Sector: Healthcare

The share price of Charles River Laboratories International, Inc. (CRL) now

Latest session on the 5th of December for
Charles River Laboratories International, Inc. is negative
Trading Volume: 330071
Open: 199.28 /  High: 199.28 /  Low: 196
What analysts predict: $211.11
52-week High/Low: $262 / $161.65

50/200 Day Moving Average: $187.61 / $201.09

This figure corresponds to the Average Price over the previous 50/200 days. For Charles River Laboratories International stocks, the 50-day moving average is the support level today.

For Charles River Laboratories International stocks, the 200-day moving average is the resistance level today.

Are you interested in Charles River Laboratories International, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Charles River Laboratories International stock price in 2023, 2024, 2025, 2026, 2027. How much will one Charles River Laboratories International share be worth in 2023 - 2027?

When should I take profit in Charles River Laboratories International stock? When should I record a loss on Charles River Laboratories International stock? What are analysts' forecasts for Charles River Laboratories International stock? What is the future of Charles River Laboratories International stock? We forecast Charles River Laboratories International stock performance using neural networks based on historical data on Charles River Laboratories International stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Charles River Laboratories International stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2023, 2024, 2025, 2026 and 2027) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Charles River Laboratories International shares. This happens once a day.




Historical and forecast chart of Charles River Laboratories International stock

The chart below shows the historical price of Charles River Laboratories International stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Charles River Laboratories International stock price can be found in the table below.

Long-term forecasts by years.

Charles River Laboratories International, Inc., an early stage contract research company, provides drug discovery, non-clinical development and safety testing services in the United States, Europe, Canada, Asia Pacific and worldwide. It operates across three segments: Research Models and Services (RMS), Security Discovery and Assessment (DSA), and Manufacturing Support (Manufacturing). The RMS segment manufactures and markets lines of research models and specially bred rats and mice for use by researchers.

Charles River Laboratories International daily forecast for a month

Date Target Pes. Opt. Vol., %
Dec 07 201.29 199.19 202.90 1.86
Dec 08 200.90 199.26 202.41 1.58
Dec 09 200.64 198.65 201.41 1.39
Dec 10 200.10 198.82 200.90 1.05
Dec 11 200.29 198.97 202.18 1.61
Dec 12 200.61 199.36 202.31 1.48
Dec 13 199.00 197.28 200.63 1.69
Dec 14 200.05 198.52 202.04 1.77
Dec 15 197.49 195.69 198.82 1.60
Dec 16 194.52 192.69 196.80 2.13
Dec 17 192.28 189.91 193.73 2.01
Dec 18 192.04 190.56 193.42 1.50
Dec 19 191.94 191.33 194.06 1.43
Dec 20 194.98 193.08 195.80 1.41
Dec 21 197.70 196.69 199.53 1.45
Dec 22 199.09 198.26 200.59 1.17
Dec 23 201.42 199.39 202.74 1.68
Dec 24 202.87 202.05 204.75 1.33
Dec 25 199.91 197.77 201.42 1.84
Dec 26 201.35 200.16 202.16 1.00
Dec 27 202.35 200.93 204.52 1.79
Dec 28 200.70 199.22 201.63 1.21
Dec 29 201.86 199.37 203.63 2.14
Dec 30 202.69 201.72 205.09 1.67
Dec 31 203.28 201.07 205.75 2.33
Jan 01 203.83 201.22 206.15 2.45
Jan 02 204.68 202.06 206.25 2.07
Jan 03 202.35 201.09 203.88 1.38
Jan 04 201.87 199.41 203.71 2.15
Jan 05 202.22 200.77 204.29 1.76

Charles River Laboratories International Daily Price Targets


Charles River Laboratories International Stock Forecast 12-07-2023.

Forecast target price for 12-07-2023: $201.29.
Positive dynamics for Charles River Laboratories International shares will prevail with possible volatility of 1.826%.
Pessimistic target level: 199.19
Optimistic target level: 202.90

Charles River Laboratories International Stock Forecast 12-08-2023.

Forecast target price for 12-08-2023: $200.90.
Negative dynamics for Charles River Laboratories International shares will prevail with possible volatility of 1.556%.
Pessimistic target level: 199.26
Optimistic target level: 202.41

Charles River Laboratories International Stock Forecast 12-09-2023.

Forecast target price for 12-09-2023: $200.64.
Negative dynamics for Charles River Laboratories International shares will prevail with possible volatility of 1.370%.
Pessimistic target level: 198.65
Optimistic target level: 201.41

Charles River Laboratories International Stock Forecast 12-10-2023.

Forecast target price for 12-10-2023: $200.10.
Negative dynamics for Charles River Laboratories International shares will prevail with possible volatility of 1.036%.
Pessimistic target level: 198.82
Optimistic target level: 200.90

Charles River Laboratories International Stock Forecast 12-11-2023.

Forecast target price for 12-11-2023: $200.29.
Positive dynamics for Charles River Laboratories International shares will prevail with possible volatility of 1.585%.
Pessimistic target level: 198.97
Optimistic target level: 202.18

Charles River Laboratories International Stock Forecast 12-12-2023.

Forecast target price for 12-12-2023: $200.61.
Positive dynamics for Charles River Laboratories International shares will prevail with possible volatility of 1.460%.
Pessimistic target level: 199.36
Optimistic target level: 202.31

CRL (CRL) Monthly Stock Prediction for 2023

Month Target Pes. Opt. Vol., %
Dec. 203.15 193.76 210.40 7.91

Charles River Laboratories International forecast for this year


Charles River Laboratories International Stock Prediction for Dec 2023

An uptrend is forecast for this month with an optimal target price of $203.146. Pessimistic: $193.76. Optimistic: $210.40



Charles River Laboratories International (CRL) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Jan 215.66 212.19 220.64 3.83
Feb 222.91 210.42 229.46 8.30
Mar 208.86 204.77 212.23 3.51
Apr 205.79 201.04 214.00 6.06
May 199.89 191.77 206.74 7.24
Jun 205.48 197.86 214.69 7.84
Jul 210.81 204.61 219.07 6.60
Aug 213.31 205.85 216.30 4.83
Sep 203.01 198.89 213.95 7.04
Oct 199.46 193.18 210.49 8.23
Nov 198.20 189.88 201.81 5.91
Dec 194.18 188.06 201.38 6.61

Charles River Laboratories International (CRL) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 204.92 199.61 208.07 4.07
Mar 214.96 209.24 225.79 7.33
Mar 228.20 217.66 235.55 7.60
Apr 242.42 239.02 253.95 5.88
May 257.52 243.64 261.30 6.76
Jun 269.78 259.58 281.30 7.72
Jul 277.52 265.09 289.76 8.51
Aug 275.77 265.92 280.60 5.23
Sep 282.53 269.08 295.97 9.09
Oct 280.15 268.39 287.21 6.55
Nov 273.49 258.55 284.59 9.15
Dec 272.91 266.99 287.43 7.11

Charles River Laboratories International (CRL) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 265.08 255.24 276.95 7.84
Mar 277.14 269.38 283.15 4.86
Mar 286.06 273.25 292.67 6.64
Apr 278.85 270.07 291.15 7.24
May 283.15 273.64 291.47 6.12
Jun 267.29 258.31 279.83 7.69
Jul 273.65 268.10 279.02 3.91
Aug 276.34 267.44 286.97 6.81
Sep 267.63 254.52 278.87 8.73
Oct 259.39 249.40 263.75 5.44
Nov 274.46 266.39 288.10 7.54
Dec 279.07 273.60 286.69 4.57

Charles River Laboratories International (CRL) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 271.06 267.08 275.61 3.10
Mar 280.55 272.10 288.01 5.52
Mar 267.39 261.96 276.00 5.09
Apr 250.92 241.43 260.40 7.28
May 243.37 233.83 250.52 6.66
Jun 238.09 231.09 245.08 5.71
Jul 254.75 247.44 267.95 7.65
Aug 268.30 253.65 273.37 7.21
Sep 261.54 250.92 266.30 5.78
Oct 265.57 258.13 280.44 7.95
Nov 258.69 250.36 264.12 5.21
Dec 262.86 255.86 271.69 5.82

Charles River Laboratories International information and performance

Charles River Laboratories International Address

251 BALLARDVALE ST, WILMINGTON, MA, US

Market Capitalization: 10 014 161 000 $

Market capitalization of the Charles River Laboratories International, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of CRL shares in the company outstanding by the market price of one share.

EBITDA: 972 454 000 $

EBITDA of Charles River Laboratories International is earnings before interest, income tax and depreciation of assets.

PE Ratio: 21.15

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: 1.605

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: 0.024

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: 9.23

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: -0.101
Quarterly Revenue Growth YOY: 0.038
Trailing PE: 21.15

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: 16.98

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 3.027

Enterprise Value (EV) /Revenue

EV To EBITDA: 11.96

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 51297000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A



Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.